Natera (NTRA) Competitor Comparison
We are evaluating the key criteria listed to compare Natera (NTRA) against its competitors in the Diagnostics & Research industry.
Market Capitalization
18 / 58Gross Profits
25 / 52Total Revenue
23 / 57EBITDA
56 / 56Free Cashflow
54 / 56Quick Ratio
18 / 57Earnings per Share
48 / 56Dividend yield
0 / 9Total Cash
8 / 57Performance 3 years
7 / 58Performance 5 years
4 / 58Performance 10 years
5 / 58Linearity 3 years
17 / 58Linearity 5 years
55 / 58Linearity 10 years
56 / 58Total Rank
24 / 58Dividend Rank
23 / 58Valuation Rank
44 / 58Piotroski Rank
34 / 58Muliplier Rank
57 / 58Performance 3 years - NTRA ranking 7 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.